This proposed Supporting Effective Coverage of Health Technology in the Pacific (the project) will form part of the regional response to reduce the number of cervical cancer cases and other infectious diseases in children and women. The project proposes to use the introduction of new vaccines and early detection through communicable disease platforms to drive necessary improvements in the public health system in selected Pacific DMCs in line with the Asia Pacific Strategy for Emerging Diseases and Public Health Emergency
| Project Name | Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project | ||||||||||||||||||||
| Project Number | 50282-001 | ||||||||||||||||||||
| Country | Regional Samoa Tonga Tuvalu Vanuatu |
||||||||||||||||||||
| Project Status | Approved | ||||||||||||||||||||
| Project Type / Modality of Assistance | Grant Loan |
||||||||||||||||||||
| Source of Funding / Amount |
|
||||||||||||||||||||
| Strategic Agendas | Inclusive economic growth Regional integration |
||||||||||||||||||||
| Drivers of Change | Gender Equity and Mainstreaming Governance and capacity development Knowledge solutions Partnerships |
||||||||||||||||||||
| Sector / Subsector | Health / Disease control of communicable disease - Health system development |
||||||||||||||||||||
| Gender Equity and Mainstreaming | Gender equity | ||||||||||||||||||||
| Description | This proposed Supporting Effective Coverage of Health Technology in the Pacific (the project) will form part of the regional response to reduce the number of cervical cancer cases and other infectious diseases in children and women. The project proposes to use the introduction of new vaccines and early detection through communicable disease platforms to drive necessary improvements in the public health system in selected Pacific DMCs in line with the Asia Pacific Strategy for Emerging Diseases and Public Health Emergency | ||||||||||||||||||||
| Project Rationale and Linkage to Country/Regional Strategy | Human papillomavirus (HPV) causes almost all cervical cancers through communicable disease transmission. Cervical cancer is a major cause of premature death in the Pacific causing nearly 500 deaths in 2010 and is therefore a leading cause of death among women in 2010 across the Pacific region. It is largely preventable through cost effective interventions of early detection and HPV vaccination. Immunization is pro-poor, providing relatively larger benefits to low-income households. | ||||||||||||||||||||
| Impact | Reducing the incidence and prevalence of cervical cancer in the Pacific region Children are nurtured in body and mind |
||||||||||||||||||||
| Project Outcome | |
|---|---|
| Description of Outcome | Effective coverage of new vaccine introduction (HPV, PCV, RV) |
| Progress Toward Outcome | |
| Implementation Progress | |
| Description of Project Outputs | New vaccines in participating DMCs introduced Regional pooled procurement strengthened Vaccine delivery through supply chain management and information systems for effective coverage in participating DMCs strengthened Awareness of vaccines in key stakeholder groups increased |
| Status of Implementation Progress (Outputs, Activities, and Issues) | |
| Geographical Location | Samoa - Nation-wide; Tonga - Nation-wide; Tuvalu - Nation-wide; Vanuatu - Nation-wide |
| Safeguard Categories | |
|---|---|
| Environment | C |
| Involuntary Resettlement | C |
| Indigenous Peoples | C |
| Summary of Environmental and Social Aspects | |
|---|---|
| Environmental Aspects | The project will have no adverse environmental impacts. |
| Involuntary Resettlement | The project will have minimal or no adverse social impacts. |
| Indigenous Peoples | The project will have minimal or no adverse social impacts. |
| Stakeholder Communication, Participation, and Consultation | |
| During Project Design | The project will impact women and children. During project preparation, consultation and participation will include: (i) group discussions with (potential) beneficiaries, health workers, and community-based organizations; (ii) consultation of health staff and district health managers, sub-national level government administration, central ministries, and partners; and (iii) where appropriate, workshop with ministries, partners, and nongovernment organizations. |
| During Project Implementation | Project outputs include increase in awareness of vaccines in key stakeholder groups. Support will be provided to Ministries of Education and Health and nongovernment organizations/civil society to develop health promotion strategies on the importance of vaccination/screening. |
| Business Opportunities | |
|---|---|
| Consulting Services | All consultants will be recruited according to ADB's Guidelines on the Use of Consultants. |
| Procurement | Any procurement of equipment or consulting services will conform with ADB's Procurement Guidelines. |
| Responsible ADB Officer | ADB Disclosure |
| Responsible ADB Department | Pacific Department |
| Responsible ADB Division | Urban, Social Development & Public Management Division, PARD |
| Executing Agencies |
Ministry of Finance Ministry of Finance Government of Samoa Private Bag, Apia, Samoa Ministry of Finance and Economic Development Private Bag Funafuti Tuvalu Ministry of Finance and National Planning Vuna Road Nuku'alofa Kingdom of Tonga Ministry of Finance, Commerce, Trade & Tourism P.O. Box 381 Constitution Bldg., Kumul Highway Port Vila, Republic of Vanuatu |
| Timetable | |
|---|---|
| Concept Clearance | 10 Jan 2017 |
| Fact Finding | 10 Apr 2018 to 19 Apr 2018 |
| MRM | 09 Aug 2018 |
| Approval | 08 Nov 2018 |
| Last Review Mission | - |
| Last PDS Update | 08 Nov 2018 |
Grant 0623-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 08 Nov 2018 | - | - | 31 May 2024 | - | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 12.06 | Cumulative Contract Awards | |||
| ADB | 7.50 | 08 Nov 2018 | 0.00 | 0.00 | 0% |
| Counterpart | 4.56 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 08 Nov 2018 | 0.00 | 0.00 | 0% |
Grant 0624-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 08 Nov 2018 | - | - | 31 May 2024 | - | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 3.85 | Cumulative Contract Awards | |||
| ADB | 3.85 | 08 Nov 2018 | 0.00 | 0.00 | 0% |
| Counterpart | 0.00 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 08 Nov 2018 | 0.00 | 0.00 | 0% |
Grant 0625-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 08 Nov 2018 | - | - | 31 May 2024 | - | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 2.50 | Cumulative Contract Awards | |||
| ADB | 2.50 | 08 Nov 2018 | 0.00 | 0.00 | 0% |
| Counterpart | 0.00 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 08 Nov 2018 | 0.00 | 0.00 | 0% |
Grant 0626-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 08 Nov 2018 | - | - | 31 May 2024 | - | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 9.00 | Cumulative Contract Awards | |||
| ADB | 9.00 | 08 Nov 2018 | 0.00 | 0.00 | 0% |
| Counterpart | 0.00 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 08 Nov 2018 | 0.00 | 0.00 | 0% |
Loan 3736-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 08 Nov 2018 | - | - | 31 May 2024 | - | - |
| Financing Plan | Loan Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 2.25 | Cumulative Contract Awards | |||
| ADB | 2.25 | 08 Nov 2018 | 0.00 | 0.00 | 0% |
| Counterpart | 0.00 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 08 Nov 2018 | 0.00 | 0.00 | 0% |
Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.
The Public Communications Policy (PCP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.
The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.
In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.
| Title | Document Type | Document Date |
|---|---|---|
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project: Report and Recommendation of the President | Reports and Recommendations of the President | Oct 2018 |
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project: Gender Action Plan | Gender Action Plans | Oct 2018 |
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project: Project Administration Manual | Project/Program Administration Manual | Oct 2018 |
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project: Procurement Plan | Procurement Plans | Jul 2018 |
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific: Initial Poverty and Social Analysis | Initial Poverty and Social Analysis | Jan 2018 |
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific: Project Preparatory Technical Assistance Report | Project Preparatory Technical Assistance Reports | Jan 2017 |
Safeguard Documents See also: Safeguards
Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.
None currently available.
Evaluation Documents See also: Independent Evaluation
None currently available.
Related Publications
None currently available.
The Public Communications Policy (PCP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.
Requests for information may also be directed to the InfoUnit.
-
ADB Assistance to Help Prevent Cervical Cancer, Other Infectious Diseases in Pacific
ADB's Board of Directors has approved a total financing package of $29.7 million to support the introduction of new vaccines in Samoa, Tonga, Tuvalu, and Vanuatu.
Tenders
No tenders for this project were found.
Contracts Awarded
No contracts awarded for this project were found
Procurement Plan
| Title | Document Type | Document Date |
|---|---|---|
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project: Procurement Plan | Procurement Plans | Jul 2018 |